T2 Biosystems, Inc. (TTOO)
OTCMKTS · Delayed Price · Currency is USD
0.0008
0.00 (0.00%)
At close: Oct 21, 2026
T2 Biosystems Market Cap
T2 Biosystems has a market cap or net worth of $22.44 thousand as of October 22, 2026. It is the 51,536th most valuable company in the world and the 7,572nd biggest in the United States. Its market cap has decreased by 92.73% in one year.
Market Cap
22.44K
Enterprise Value
n/a
Revenue
7.68M
Global Rank
Country Rank
#7,572 United States
PE Ratio
n/a
ChartMarket Cap Chart
Since August 7, 2014, T2 Biosystems's market cap has decreased from 274.87M to 22.44K, a decrease of -99.99%. That is a compound annual growth rate of -53.73%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 21, 2026 | 22.44K | -84.00% |
| Dec 31, 2025 | 140.23K | -98.41% |
| Dec 31, 2024 | 8.84M | -65.23% |
| Dec 29, 2023 | 25.42M | 144.54% |
| Dec 30, 2022 | 10.39M | -87.87% |
| Dec 31, 2021 | 85.67M | -53.30% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| InVitro International | 1.34M |
| Hypha Labs | 700.16K |
| NovelStem International | 468.66K |
| ProPhase Labs | 170.33K |
| Medical Imaging | 63.82K |
| CardioGenics Holdings | 14.29K |
| RushNet | 8.77K |
| Todos Medical | 3.32K |